Cargando…
Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis
BACKGROUND: Multiple sclerosis (MS) is a chronic disabling disease of the central nervous system (CNS) commonly affecting young adults. There is increasing evidence that environmental factors are important in the development and course of MS. The metabolic syndrome (MetS) which comprises dyslipidemi...
Autores principales: | Vigne, Solenne, Duc, Donovan, Peter, Benjamin, Rebeaud, Jessica, Yersin, Yannick, Ruiz, Florian, Bressoud, Valentine, Collet, Tinh-Hai, Pot, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822860/ https://www.ncbi.nlm.nih.gov/pubmed/35130916 http://dx.doi.org/10.1186/s12974-022-02409-x |
Ejemplares similares
-
Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis
por: Ruiz, Florian, et al.
Publicado: (2023) -
Oxysterols in Autoimmunity
por: Duc, Donovan, et al.
Publicado: (2019) -
How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation
por: Rebeaud, Jessica, et al.
Publicado: (2022) -
Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering Neuroinflammation
por: Fraga-Silva, Thais Fernanda de Campos, et al.
Publicado: (2019) -
Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
por: Shin, Taekyun, et al.
Publicado: (2012)